Arkolith/Insider Trading/XGN/Form 4

Aballi John

President and CEO, DirectorEXAGEN INC. (XGN) · full profile →Form 4 · filed Mar 16, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2026Grant(A)150K—$0840K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2026Grant(A)100K$3.16$316K175K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001843113-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for EXAGEN INC.

Build

Ask your agent about XGN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001843113-26-000006"
Ask your agent
Use Arkolith to summarize insider buying and selling at EXAGEN INC.
over the last 90 days and cite the filings.